Observational studyDrug design, development and therapy2019

Efficacy And Safety Of Apatinib Treatment In Platinum-Resistant Recurrent Epithelial Ovarian Cancer: A Real World Study.

Jindi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.